Release Date: 24/02/10 08:59 Summary: Half Yearly Report and Accounts Price Sensitive: Yes Download Document 308.47KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%